Why Is Thomson Reuters (TSX:TRI) Gaining Buzz After AI Rollout and $1B Buyback Announcement?

• Earlier this month, Thomson Reuters presented at Semicon West 2025 in Phoenix, highlighting advancements in its artificial intelligence-powered product offerings and announcing a US$1 billion share repurchase program approved by the Toronto Stock Exchange.
• Analyst upgrades followed these announcements, underscoring growing confidence in the company's AI-enabled revenue growth and effective capital management initiatives.
• We'll now examine how Thomson Reuters' AI-driven momentum and share buyback program influence its long-term investment narrative.

These 9 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

Thomson Reuters Investment Narrative Recap

To be a shareholder in Thomson Reuters today, you need conviction in the company's ability to convert its proprietary AI innovations into recurring revenue across legal and professional services. The recent product showcases and large-scale buyback may reinforce near-term optimism on AI-driven growth, but they do not fundamentally erase the central risk: persistent competition and potential pricing pressure in the legal technology market remain key watchpoints.

Of all recent announcements, the US$1 billion share repurchase program unveiled at Semicon West stands out, it reflects a continued focus on capital returns to shareholders amid investments in AI. While this reinforces the short-term catalyst of expanding AI-based products, it does not directly address the integration risk tied to recent acquisitions, which continues to shadow profit growth potential.

However, investors should be aware that behind the headlines of innovation and capital allocation, ongoing competition and slow client adoption may still weigh...

Read the full narrative on Thomson Reuters (it's free!)

Thomson Reuters is projected to reach $9.2 billion in revenue and $2.1 billion in earnings by 2028. This outlook assumes a 7.8% annual revenue growth rate and a $0.5 billion increase in earnings from the current level of $1.6 billion.

Uncover how Thomson Reuters' forecasts yield a CA$277.20 fair value, a 24% upside to its current price.

Exploring Other Perspectives

Across four recent fair value estimates from the Simply Wall St Community, TRI's fair value ratings span from US$186.45 to US$277.20 per share. While many foresee upside on AI-led growth, keep in mind that persistent integration challenges could affect the company's ability to deliver sustained earnings improvement, compare these viewpoints side by side for a fuller picture.

Explore 4 other fair value estimates on Thomson Reuters - why the stock might be worth 17% less than the current price!

Build Your Own Thomson Reuters Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Thomson Reuters research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Thomson Reuters research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Thomson Reuters' overall financial health at a glance.

Ready For A Different Approach?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• The end of cancer? These 28 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• We've found 18 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com